198HO02262 PARAGUAY

Print/PDF
Registration Name SANDY-VALLEY PARAGUAY-ET
Registration Number HO840003209481487
Primary NAAB Code 198HO02262
Secondary Code(s) 598HO02262
Status Progeny Test
Controller Name INTERMIZOO S.p.A. (198)
Date of Birth 12/9/2020
aAa 342516
DMS -
GFI 12.9%
Genetic Codes * TY TL TV TD TC TP TR TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T
Sire SIEMERS RENGD PARFECT-ET
MGS PINE-TREE CW LEGACY-ET
Beta Casein A2A2
Kappa Casein BB
Beta Lactoglobulin AA
INDEXES
NM$ 330, 82% R CM$ 386
NM Percentile 35% FM$ 202
GTPI 3032 GM$ 317
PRODUCTION TRAITS
265 Dtrs 129 herds 0 % US 90% R
Milk -302 Fat, % 23 , +0.14%
SCS 2.66, 88% R Protein, % 26 , +0.14%
Feed Saved -316 , 57% R Milking Speed 6.97 , 69% R
Health & Fertility
Productive Life 4.4      82% R Mastitis 4.4      77% R
Heifer Livability 0.0       61% R Metritis 0.3      74% R
Livability 0.9      79% R D. Abom 0.9      76% R
DPR 2.3      83% R Ketosis 1.0      74% R
HCR 3.4      84% R R. Placenta -0.4      75% R
FSC 10.2      80% R Milk Fever 0.0      68% R
CCR 4.0      82% R
SCR -        -
DIA 0.6      50% R
RSP -0.1      57% R
Calving Traits
Sire CE 1.5      73% R 954 Obs
Daughter CE 1.5      51% R 0 Obs, 753 Dtrs
Sire SB 3.6      51% R 1024 Obs
Daughter SB 3.8      50% R 0 Obs, Dtrs
Gestation Length 1.7      78% R 0 Obs, 0 Dtrs
Early First Calving 2.9      78% R 0 Obs, 0 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
189 Dtrs 87 herds 88% R
PTA Type 0.53 UDC 0.78
HCC 2.12 BWC 1.35
FLC 1.13
Linear Traits
Stature -0.41
Short
Strength 0.92
Weak
Body Depth -0.17
Shallow
Dairy Form -1.46
Closed
Rump Angle -1.50
Flat
Thurl Width 0.67
Wide
Rear Legs-Side View -0.76
Straight
Rear Legs-Rear View 1.72
Straight
Foot Angle 1.21
Steep
Feet & Legs Score 0.74
High
F.U. Attachment 1.41
Strong
Rear Udder Height 0.60
High
Rear Udder Width 0.38
Wide
Udder Cleft 0.02
Strong
Udder Depth 1.23
Shallow
Front Teat Placement -0.68
Wide
Rear Teat Placement -0.29
Wide
Teat Length 0.91
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO